Like a self-assembling ‘Lego Death Star’, says lead researcher
Researchers have developed a simple and versatile method for making artificial anti-cancer molecules that mimic the properties of one of the body’s natural defence systems.
The chemists, led by Professor Peter Scott at the University of Warwick, UK, have been able to produce molecules that have a similar structure to peptides which are naturally produced in the body to fight cancer and infection.
Published in Nature Chemistry, the molecules produced in the research have proved effective against colon cancer cells in laboratory tests, in collaboration with Roger Phillips at the Institute for Cancer Therapeutics, Bradford, UK.
Artificial peptides had previously been difficult and prohibitively expensive to manufacture in large quantities, but the new process takes only minutes and does not require costly equipment. Also, traditional peptides that are administered as drugs are quickly neutralised by the body’s biochemical defences before they can do their job.
Reaad more . . .
The Latest on: Anti-cancer molecules
[google_news title=”” keyword=”Anti-cancer molecules” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Anti-cancer molecules
- Targeting specific protein regions offers a new treatment approach in medulloblastomaon April 25, 2024 at 12:32 pm
Medulloblastoma (the most common malignant childhood brain tumor) is separated into four molecular groups, with Group 3 bearing the worst prognosis. By studying EP300 and CBP, critical proteins in ...
- John Cleese is spending thousands on stem cell therapy – is it really the secret to anti-ageing?on April 24, 2024 at 9:59 pm
They also produce anti-inflammatory molecules, which could counteract lots of age-related ... and when you introduce cells that can divide into any cell type, cancer can be a concern too. So the ...
- Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meetingon April 24, 2024 at 7:02 pm
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, ...
- Scientists identify and show how to target a key tumor defense against immune attackon April 23, 2024 at 5:00 pm
A new study has discovered how a lipid molecule found at high levels within tumors undermines the anti-cancer immune response and compromises a recently approved immunotherapy known as adoptive cell ...
- Beiersdorf Unveils Breakthrough Anti-Glycation Ingredient to Combat Sugar-Induced Skin Agingon April 23, 2024 at 3:55 am
After nearly a decade of research, Beiersdorf has revealed a groundbreaking discovery in skincare: a patented active ingredient called NAHP, also ...
- Liver cells effectively serve as immune checkpoint regulating anti-cancer immunityon April 22, 2024 at 1:03 pm
Liver inflammation, a common side-effect of cancers elsewhere in the body, has long been associated with worse cancer outcomes and more recently associated with poor response to immunotherapy.
- CSHL’s Josh Homer produces chemical compounds with potentialon April 22, 2024 at 8:51 am
Homer found that eight of the microtubule targeting agents were more potent than colchicine against HCT-15. This cancer cell line, he explained, is known to have upregulated efflux, which is a major ...
- New Cancer Immunotherapy Balances Efficacy and Safetyon April 20, 2024 at 5:00 am
The new immunotherapy employing cytokine proteins offers a promising treatment avenue, targeting tumors while preserving healthy cells from damage.
- Researchers develop a new way to safely boost immune cells to fight canceron April 19, 2024 at 11:01 am
Last year alone, more than 600,000 people in the United States died from cancer, according to the American Cancer Society. The relentless pursuit of understanding this complex disease has shaped ...
- Study finds how liver inflammation associated with poor cancer outcomeson April 19, 2024 at 8:05 am
Liver inflammation, a typical side effect of malignancies elsewhere in the body, has long been associated with poor cancer outcomes and, more recently, with poor response to immunotherapy. A team of ...
via Bing News